Bone radionuclide therapy and increased survival with radium-223 is the way to go for nuclear medicine: the offer that oncologists cannot refuse

Eur J Nucl Med Mol Imaging. 2018 May;45(5):822-823. doi: 10.1007/s00259-017-3913-z. Epub 2018 Jan 14.

Authors

Roberto C Delgado Bolton¹, Francesco Giammarile²

Affiliations

¹ Department of Diagnostic Imaging and Nuclear Medicine, University Hospital San Pedro and Centre for Biomedical Research of La Rioja (CIBIR), Logroño, La Rioja, Spain. rbiolton@gmail.com.
² International Atomic Energy Agency (IAEA), Nuclear Medicine and Diagnostic Imaging Section, Vienna, Austria.

PMID: 29333576
DOI: 10.1007/s00259-017-3913-z

No abstract available

Publication types

Editorial
Introductory Journal Article

MeSH terms

Bone Neoplasms / radiotherapy*
Humans
Nuclear Medicine / trends*
Oncologists
Radioisotopes
Radionuclide Imaging
Radium / therapeutic use*

Substances

Radioisotopes
Radium-223
Radium